Table 1.
Sociodemographic, clinical, and structural characteristics of transgender women in the LITE cohort by prevention-effective adherence trajectory (N=728)
| Factor | Full sample | Group 0: Never indicated/no PrEP | Group 1: Consistent indication/no PrEP | Group 2: Initial indication/no PrEP | Group 3: Declining indication/discontinued PrEP | Group 4: Consistent indication/PrEP adherent | Group 5: Increasing indication/initiated PrEP | p-value (χ2 test) |
|---|---|---|---|---|---|---|---|---|
| n | 728 | 188 | 77 | 263 | 52 | 99 | 49 | |
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Youth (Aged 18–24) | 214 (29.4) | 43 (22.9) | 16 (20.8) | 103 (39.2) | 16 (30.8) | 18 (18.2) | 18 (36.7) | <0.001 |
| Black | 235 (32.6) | 29 (15.7) | 30 (39.0) | 88 (33.7) | 23 (45.1) | 39 (39.4) | 26 (55.3) | <0.001 |
| Latina | 190 (26.5) | 22 (11.8) | 23 (29.9) | 78 (30.5) | 18 (36.7) | 35 (35.4) | 14 (29.2) | <0.001 |
| Census division | <0.001 | |||||||
| New England | 158 (21.7) | 63 (33.5) | 11 (14.3) | 55 (20.9) | 8 (15.4) | 13 (13.1) | 8 (16.3) | |
| Mid-Atlantic | 221 (30.4) | 47 (25.0) | 21 (27.3) | 86 (32.7) | 22 (42.3) | 31 (31.3) | 14 (28.6) | |
| South Atlantic | 349 (47.9) | 78 (41.5) | 45 (58.4) | 122 (46.4) | 22 (42.3) | 55 (55.6) | 27 (55.1) | |
| College education or higher | 464 (64.4) | 141 (75.0) | 45 (58.4) | 164 (63.1) | 20 (39.2) | 69 (71.1) | 25 (52.1) | <0.001 |
| Homelessness¶ | 163 (22.5) | 23 (12.3) | 20 (26.0) | 67 (25.6) | 19 (36.5) | 17 (17.2) | 17 (34.7) | <0.001 |
| Arrest ¶ | 42 (5.8) | 2 (1.1) | 10 (13.0) | 17 (6.5) | 2 (4.0) | 5 (5.1) | 6 (12.2) | <0.01 |
| Uninsured¶ | 80 (11.6) | 16 (8.7) | 15 (19.7) | 31 (12.8) | 4 (7.8) | 8 (8.9) | 6 (13.0) | 0.15 |
| Lab-confirmed STI¶ | 102 (14.0) | 0 (0.0) | 30 (39.0) | 27 (10.3) | 12 (23.1) | 21 (21.2) | 12 (24.5) | <0.001 |
| One or more current partner(s) using PrEP¶ | 215 (29.7) | 18 (9.7) | 22 (28.6) | 61 (23.3) | 26 (51.0) | 61 (61.6) | 27 (55.1) | <0.001 |
| Six months or longer since last healthcare encounter | 53 (7.4) | 10 (5.4) | 13 (17.1) | 19 (7.3) | 2 (3.8) | 4 (4.0) | 5 (10.2) | 0.01 |
| Anticipated discrimination in healthcare | 301 (42.2) | 90 (47.9) | 31 (40.8) | 103 (40.7) | 21 (42.0) | 43 (43.4) | 13 (27.7) | 0.23 |
¶
At any point over follow-up. All other indicators were assessed at baseline only.